Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial.

Montorsi F, Padma-Nathan H, Buvat J, Schwaibold H, Beneke M, Ulbrich E, Bandel TJ, Porst H; Vardenafil Study Group..

J Sex Med. 2004 Sep;1(2):168-78.

PMID:
16422971
2.

Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction.

Donatucci C, Taylor T, Thibonnier M, Bangerter K, Gittelman M, Casey R; Vardenafil Study Group..

J Sex Med. 2004 Sep;1(2):185-92.

PMID:
16422973
3.

Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study.

Rosenberg MT, Adams PL, McBride TA, Roberts JN, McCallum SW.

Int J Clin Pract. 2009 Jan;63(1):27-34. doi: 10.1111/j.1742-1241.2008.01947.x.

4.

Duration of erection: does it really matter? A randomized, double-blind clinical trial to assess the impact of vardenafil ODT on duration of erection and its correlation with patients' and partners' sexual quality of life and duration of intercourse: the VADEOPEN study.

Martin-Morales A, Gutiérrez-Hernández P, Romero-Otero J, Romero-Martín JA; Vadeopen Study Group..

J Sex Med. 2014 Jun;11(6):1527-38. doi: 10.1111/jsm.12496. Epub 2014 Mar 13.

PMID:
24628736
5.

Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.

Hatzichristou DG, Aliotta P, Auerbach S, Barkin J, Lording D, Murdock M, Wilkins HJ, McBride TA, Colopy MW, Carson CC; Patient Response with Vardenafil in Sildenafil Non-Responders (PROVEN) Study Group..

Clin Ther. 2005 Sep;27(9):1452-61.

PMID:
16291418
6.

Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis.

Valiquette L, Montorsi F, Hellstrom WJ, Giuliano F, Homering M, Taylor T, Eardley I; Vardenafil Study Group..

Can J Urol. 2005 Jun;12(3):2687-98; discussion 2699.

PMID:
16011816
7.

Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury.

Giuliano F, Rubio-Aurioles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wilkins HJ, Wachs BH; Vardenafil Study Group..

Neurology. 2006 Jan 24;66(2):210-6.

PMID:
16434656
8.

The efficacy and safety of vardenafil in East Asian men with erectile dysfunction.

Chen KK, Paick JS, Ishii N; Vardenafil Study Group..

J Sex Med. 2007 May;4(3):753-61.

PMID:
17498108
9.

Vardenafil allows successful intercourse initiated rapidly after dosing in Japanese patients with diabetes mellitus and erectile dysfunction.

Nagao K, Kobayashi H, Fujikawa K, Tachibana T, Iwamoto Y, Ishii N, Turek PJ, Brant WO, Kamidono S.

J Sex Med. 2009 Oct;6(10):2851-7. doi: 10.1111/j.1743-6109.2009.01439.x. Epub 2009 Aug 28.

PMID:
19732311
11.

Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study.

Porst H, Sharlip ID, Hatzichristou D, Rubio-Aurioles E, Gittelman M, Stancil BN, Smith PM, Wilkins HJ, Pommerville P; Vardenafil Study Group..

Eur Urol. 2006 Nov;50(5):1086-94; discussion 1094-5. Epub 2006 Jun 8.

PMID:
16820261
12.

Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives.

van Ahlen H, Wahle K, Kupper W, Yassin A, Reblin T, Neureither M.

J Sex Med. 2005 Nov;2(6):856-64. Erratum in: J Sex Med. 2006 Jan;3(1):190.

PMID:
16422810
13.

Sustained efficacy and safety of vardenafil for treatment of erectile dysfunction: a randomized, double-blind, placebo-controlled study.

Valiquette L, Young JM, Moncada I, Porst H, Vézina JG, Stancil BN, Edmunds K, Montorsi F; Vardenafil Study Group..

Mayo Clin Proc. 2005 Oct;80(10):1291-7.

PMID:
16212141
14.
15.

Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations.

Debruyne FM, Gittelman M, Sperling H, Börner M, Beneke M.

J Sex Med. 2011 Oct;8(10):2912-23. doi: 10.1111/j.1743-6109.2011.02462.x. Epub 2011 Aug 30.

PMID:
21883954
16.

Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial.

Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H; Vardenafil Study Group..

Urology. 2003 Apr;61(4 Suppl 1):8-14.

PMID:
12657355
17.

The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.

Sperling H, Debruyne F, Boermans A, Beneke M, Ulbrich E, Ewald S.

J Sex Med. 2010 Apr;7(4 Pt 1):1497-507. doi: 10.1111/j.1743-6109.2010.01806.x. Epub 2010 Mar 3.

PMID:
20233275
18.

Vardenafil restores erectile function to normal range in men with erectile dysfunction.

Padma-Nathan H, Montorsi F, Giuliano F, Meuleman E, Auerbach S, Eardley I, McCullough A, Homering M, Segerson T; North American and European Vardenafil Study Group..

J Sex Med. 2007 Jan;4(1):152-61.

PMID:
17233781
19.

[Efficacy and safety of oral vardenafil in the treatment of erectile dysfunction].

Pan T, Zhuang S, Ma H, Hong K, Tang W.

Zhonghua Nan Ke Xue. 2004 Dec;10(12):955-9. Chinese.

PMID:
15638033
20.

Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial.

Schneider T, Gleissner J, Merfort F, Hermanns M, Beneke M, Ulbrich E.

J Sex Med. 2011 Oct;8(10):2904-11. doi: 10.1111/j.1743-6109.2011.02383.x. Epub 2011 Jul 19.

PMID:
21771281

Supplemental Content

Support Center